Colitis, ulcerative Trials in Székesfehérvár, Hungary
Conditions / Colitis, ulcerative / Székesfehérvár, Hungary
Research into Colitis, ulcerative spans multiple therapeutic approaches and trial phases.
11 total trials for this combination
Showing top 10 of 11 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT02620046 | A Study of Long-term Effects of Vedolizumab Subcutaneous in Adults With Ulcerative Colitis and Crohn's Disease | COMPLETED | PHASE3 |
| NCT00487539 | An Efficacy and Safety Study of Golimumab (CNTO 148) in Participants With Moderately to Severely Active Ulcerative Colitis | COMPLETED | PHASE2/PHASE3 |
| NCT05499130 | A Study to Test the Effect of TEV-48574 in Moderate to Severe Ulcerative Colitis or Crohn's Disease | COMPLETED | PHASE2 |
| NCT05156125 | VTX002 Versus Placebo for the Treatment of Moderately to Severely Active Ulcerative Colitis | TERMINATED | — |
| NCT05611671 | A Study to Evaluate MORF-057 in Adults With Moderately to Severely Active UC | ACTIVE_NOT_RECRUITING | PHASE2 |
| NCT02407236 | A Study to Evaluate the Safety and Efficacy of Ustekinumab Induction and Maintenance Therapy in Participants With Moderately to Severely Active Ulcerative Colitis | COMPLETED | PHASE3 |
| NCT02611830 | Efficacy and Safety of Vedolizumab Subcutaneously (SC) as Maintenance Therapy in Ulcerative Colitis | COMPLETED | PHASE3 |
| NCT00488774 | An Efficacy and Safety Study of Golimumab in Participants With Ulcerative Colitis | TERMINATED | PHASE2/PHASE3 |
| NCT00488631 | An Efficacy and Safety Study of Golimumab (CNTO 148) in Participants With Moderately to Severely Active Ulcerative Colitis | COMPLETED | PHASE3 |
| NCT07012395 | A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis | RECRUITING | — |